Percutaneous cementoplasty for acetabulum in patients with bone metastasis
- Authors
- Choi, Eun-Seok; Kim, Yong-il; Kang, Hyun Guy; Kim, June Hyuk; Kim, Han Soo; Lin, Patrick P.
- Issue Date
- 2017
- Publisher
- ACTA MEDICA BELGICA
- Keywords
- Percutaneous Cementoplasty; Acetabulum; Metastasis; F-18-FDGPET/CT
- Citation
- ACTA ORTHOPAEDICA BELGICA, v.83, no.3, pp.480 - 487
- Journal Title
- ACTA ORTHOPAEDICA BELGICA
- Volume
- 83
- Number
- 3
- Start Page
- 480
- End Page
- 487
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/7559
- ISSN
- 0001-6462
- Abstract
- The purpose of this study is to demonstrate the surgical technique and to show the results of percutaneous cementoplasty (PC) for acetabular metastases using lateral approach under regional anesthesia. Forty-two cases underwent PC for acetabular metastases. The PC was performed using spinal anesthesia, lateral approach and fluoroscopic guidance. We assessed visual analogue scale (VAS) and revised musculoskeletal tumor society (MSTS) rating system and maximum standardized uptake value (SUVmax) of the acetabular lesion using F-18-FDG PET/CT before and after the PC. The mean injected volume of polymethylmethacrylamide to the pelvis was 21 +/- 11.8 ml. The mean of regional VAS (6.2 +/- 1.1 vs. 3.1 +/- 2.7, p< 0.001), MSTS (10.3 +/- 3.9 vs. 18.3 +/- 3.2, p< 0.001) and local SUVmax (8.6 +/- 5.2 vs. 5.7 +/- 3.6, p = 0.012) on PET/CT showed significant reductions after surgery. Twenty-three patients (55%) died of disease at mean 11.8 +/- 4.8 months after surgery. PC using lateral approach and regional anesthesia could be a simple and safe surgical method for relieving pain and maintaining skeletal stability against acetabular metastasis.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/7559)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.